Floatz logo

Cotrimoxazole

Life-threatening Infection

University of OxfordPhase 3Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Life-threatening Infection cohort.

Asset / SponsorPhaseRating
Cotrimoxazole Dispersible
University of Oxford
Phase 3BB

Same molecule, other indications

Cotrimoxazole is also rated in:

Nutrition DisordersDormant
CCC
Indicative ·
52 / 100
View asset →
peritonitisDormant
CCC
Indicative ·
50 / 100
View asset →
idiopathic pulmonary fibrosisDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →